Primary Lymphoma of Bone in Adult Patients

被引:104
作者
Jawad, Muhammad U. [1 ]
Schneiderbauer, Michaela M. [1 ]
Min, Elijah S. [2 ]
Cheung, Michael C. [3 ]
Koniaris, Leonidas G. [3 ]
Scully, Sean P. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Orthoped, Miami, FL 33136 USA
[2] Ross Univ, Sch Med, N Brunswick, NJ USA
[3] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Div Surg Oncol, Miami, FL 33136 USA
关键词
primary lymphoma of bone; survival; prognosis; radiation therapy; staging; NON-HODGKINS-LYMPHOMA; RETICULUM-CELL SARCOMA; MALIGNANT-LYMPHOMA; PROGNOSTIC-FACTORS; CHILDREN; ADRIAMYCIN; THERAPY; RISK;
D O I
10.1002/cncr.24828
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The low incidence of primary lymphoma of bone (PLB) has led to discrepancies in classification as well as difficulty in prognostication. The authors of this report used the Surveillance, Epidemiology, and End Results (SEER) database to analyze a large, population-based cohort of adult patients with this disease. The database provides a standardized classification and documentation of outcomes and enables a meaningful evaluation of prognostic factors. METHODS: The SEER database was used to identify all patients who were diagnosed with PLB from 1973 through 2005. Survival was analyzed with the Kaplan-Meier method, and the influence of clinical parameters on survival was analyzed with the log-rank test. A Cox proportional hazards model was used for multivariate analysis. RESULTS: Fifteen hundred adult patients with PLB were analyzed. The 5-year and 10-year survival rates for adult patients were 58% and 45%, respectively. Multivariate analysis revealed that younger age and localized disease were independent predictors of survival. It is noteworthy that the incidence of disease, as determined by the annual percentage change, increased during the study period (P < .05). CONCLUSIONS: This analysis of a large cohort of adults with PLB indicated that the only identifiable prognostic indicators were localized disease and younger age. The authors concluded that future treatment for patients with PLB need to be based on strict staging criteria and adherence to successful published protocols using collaborative clinical trials. Cancer 2010;116:871-9. (C) 2010 American Cancer Society
引用
收藏
页码:871 / 879
页数:9
相关论文
共 33 条
[21]   Hepatitis C and risk of lymphoma:: Results of the European Multicenter Case-Control Study EPILYMPH [J].
Nieters, Alexandra ;
Kallinowski, Birgit ;
Brennan, Paul ;
Ott, Melanie ;
Maynadie, Marc ;
Benavente, Yolanda ;
Foretova, Lenka ;
Cocco, Pier Luigi ;
Staines, Anthony ;
Vornanen, Martine ;
Whitby, Denise ;
Boffetta, Paolo ;
Becker, Nikolaus ;
De Sanjose, Silvia .
GASTROENTEROLOGY, 2006, 131 (06) :1879-1886
[22]  
Oberling C., 1928, B ASSOC FR ETUD CANC, V17, P259
[23]   PRIMARY LYMPHOMA OF BONE - A B-CELL NEOPLASM WITH A HIGH-FREQUENCY OF MULTILOBATED CELLS [J].
PETTIT, CK ;
ZUKERBERG, LR ;
GRAY, MH ;
FERRY, JA ;
ROSENBERG, AE ;
HARMON, DC ;
HARRIS, NL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1990, 14 (04) :329-334
[24]   Primary bone lymphoma: single institution case series [J].
Power, D. G. ;
Mcvey, G. P. ;
Korpanty, G. ;
Treacy, A. ;
Dervan, P. ;
O'Keane, C. ;
Carney, D. N. .
IRISH JOURNAL OF MEDICAL SCIENCE, 2008, 177 (03) :247-251
[25]   A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency [J].
Ramadan, K. M. ;
Shenkier, T. ;
Sehn, L. H. ;
Gascoyne, R. D. ;
Connors, J. M. .
ANNALS OF ONCOLOGY, 2007, 18 (01) :129-135
[26]  
RUDDERS RA, 1978, CANCER-AM CANCER SOC, V42, P406, DOI 10.1002/1097-0142(197808)42:2<406::AID-CNCR2820420205>3.0.CO
[27]  
2-H
[28]  
SHOJI H, 1971, CANCER-AM CANCER SOC, V28, P1234, DOI 10.1002/1097-0142(1971)28:5<1234::AID-CNCR2820280522>3.0.CO
[29]  
2-L
[30]   Primary lymphoma of bone - A retrospective study - Experience at the Northern Israel Oncology Center (1979-2000) [J].
Stein, ME ;
Kuten, A ;
Gez, E ;
Rosenblatt, KE ;
Drumea, K ;
Ben-Shachar, M ;
Zidan, J ;
Haim, N ;
Epelbaum, R .
ONCOLOGY, 2003, 64 (04) :322-327